{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:37:06Z","timestamp":1783355826078,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004605","name":"Zhengzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012603","name":"Startup Research Fund of Zhengzhou University","doi-asserted-by":"publisher","award":["35220828"],"award-info":[{"award-number":["35220828"]}],"id":[{"id":"10.13039\/501100012603","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.109028","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T04:12:05Z","timestamp":1758687125000},"page":"109028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Discovery of W478, a novel SHMT2 inhibitor for the treatment of esophageal carcinoma"],"prefix":"10.1016","volume":"165","author":[{"given":"Hafiz Muhammad Bilal","family":"Akram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianshu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.bioorg.2025.109028_bb0005","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.3748\/wjg.v21.i26.7933","article-title":"Esophageal cancer: risk factors, screening and endoscopic treatment in Western and eastern countries","volume":"21","author":"Arnal","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109028_bb0010","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1097\/CM9.0000000000003420","article-title":"Global esophageal cancer epidemiology in 2022 and predictions for 2050: a comprehensive analysis and projections based on GLOBOCAN data","volume":"137","author":"Qi","year":"2024","journal-title":"Chin. Med. J."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109028_bb0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3390\/cancers15030765","article-title":"Current status and future prospects for esophageal cancer","volume":"15","author":"Sheikh","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109028_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","article-title":"One-carbon metabolism in health and disease","volume":"25","author":"Ducker","year":"2017","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109028_bb0025","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/1535-7163.MCT-20-0423","article-title":"Therapeutic targeting of mitochondrial one-carbon metabolism in Cancer","volume":"19","author":"Dekhne","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109028_bb0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20181965","article-title":"Toward a better understanding of folate metabolism in health and disease","volume":"216","author":"Zheng","year":"2019","journal-title":"J. Exp. Med."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109028_bb0035","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.7150\/jca.60170","article-title":"Roles of mitochondrial serine Hydroxymethyltransferase 2 (SHMT2) in human carcinogenesis","volume":"12","author":"Zeng","year":"2021","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109028_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0378-1119(98)00085-7","article-title":"Molecular cloning, characterization and alternative splicing of the human cytoplasmic serine hydroxymethyltransferase gene","volume":"210","author":"Girgis","year":"1998","journal-title":"Gene"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109028_bb0045","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0969-2126(98)00112-9","article-title":"The crystal structure of human cytosolic serine hydroxymethyltransferase: a target for cancer chemotherapy","volume":"6","author":"Renwick","year":"1998","journal-title":"Structure"},{"issue":"14","key":"10.1016\/j.bioorg.2025.109028_bb0050","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/1873-3468.13455","article-title":"Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs","volume":"593","author":"Scaletti","year":"2019","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109028_bb0055","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/febs.13211","article-title":"How pyridoxal 5\u2032-phosphate differentially regulates human cytosolic and mitochondrial serine hydroxymethyltransferase oligomeric state","volume":"282","author":"Giardina","year":"2015","journal-title":"FEBS J."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109028_bb0060","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1158\/0008-5472.CAN-13-2683","article-title":"Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes","volume":"74","author":"Lee","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109028_bb0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13578-023-01148-7","article-title":"SHMT2 regulates esophageal cancer cell progression and immune escape by mediating m6A modification of c-myc","volume":"13","author":"Qiao","year":"2023","journal-title":"Cell Biosci."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109028_bb0070","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.3390\/ijms24087150","article-title":"SHMT2 promotes gastric Cancer development through regulation of HIF1\u03b1\/VEGF\/STAT3 signaling","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109028_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3758697","article-title":"SHMT2 drives the progression of colorectal Cancer by regulating UHRF1 expression","author":"Cui","year":"2022","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109028_bb0080","first-page":"3405","article-title":"SHMT2 promotes tumor growth through VEGF and MAPK signaling pathway in breast cancer","volume":"12","author":"Xie","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109028_bb0085","article-title":"Overexpression of SHMT2 predicts a poor prognosis and promotes tumor cell growth in bladder Cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.bioorg.2025.109028_bb0090","first-page":"653","article-title":"The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing","volume":"1","author":"Parsa","year":"2020","journal-title":"Nat. Can."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109028_bb0095","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10637-021-01144-z","article-title":"Serine hydroxymethyltransferase 2: a novel target for human cancer therapy","volume":"39","author":"Xie","year":"2021","journal-title":"Investig. New Drugs"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109028_bb0100","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1021\/jm501987h","article-title":"Inhibitors of plasmodial serine hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities","volume":"58","author":"Witschel","year":"2015","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109028_bb0105","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.18632\/oncotarget.6726","article-title":"A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells","volume":"7","author":"Marani","year":"2016","journal-title":"Oncotarget"},{"issue":"43","key":"10.1016\/j.bioorg.2025.109028_bb0110","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.1706617114","article-title":"Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma","volume":"114","author":"Ducker","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109028_bb0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41375-020-0845-6","article-title":"SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia","volume":"35","author":"Garc\u00eda-Ca\u00f1averas","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109028_bb0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","article-title":"Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance","volume":"15","author":"Gonen","year":"2012","journal-title":"Drug Resist. Updat."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109028_bb0125","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1158\/1535-7163.MCT-19-0037","article-title":"Novel Pyrrolo[3,2-d]pyrimidine compounds target mitochondrial and cytosolic one-carbon metabolism with broad-spectrum antitumor efficacy","volume":"18","author":"Dekhne","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109028_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/mol.119.117937","article-title":"Cellular pharmacodynamics of a novel Pyrrolo[3,2-d]pyrimidine inhibitor targeting mitochondrial and cytosolic one-carbon metabolism","volume":"97","author":"Dekhne","year":"2020","journal-title":"Mol. Pharmacol."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109028_bb0135","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1021\/acs.jmedchem.3c00763","article-title":"Structure-based Design of Transport-Specific Multitargeted one-Carbon Metabolism Inhibitors in cytosol and mitochondria","volume":"66","author":"Nayeen","year":"2023","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109028_bb0140","first-page":"545","article-title":"Structural characterization of 5-substituted Pyrrolo[3,2-d]pyrimidine Antifolate inhibitors in complex with human serine Hydroxymethyl transferase 2","volume":"63","author":"Katinas","year":"2024","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109028_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102036","article-title":"Structural basis for selective inhibition of human serine hydroxymethyltransferase by secondary bile acid conjugate","volume":"24","author":"Ota","year":"2021","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109028_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104349","article-title":"Glycyrrhetinic acid restricts mitochondrial energy metabolism by targeting SHMT2","volume":"25","author":"Jin","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.bioorg.2025.109028_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112260","article-title":"Metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview","volume":"194","author":"Mondal","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109028_bb0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.devcel.2014.03.012","article-title":"Cyclin B1\/Cdk1 coordinates mitochondrial respiration for cell-cycle G2\/M progression","volume":"29","author":"Wang","year":"2014","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109028_bb0165","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/encyclopedia2040111","article-title":"Apoptosis regulators Bcl-2 and Caspase-3","volume":"2","author":"Hussar","year":"2022","journal-title":"Encyclopedia"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109028_bb0170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","article-title":"Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology","volume":"23","author":"Sies","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7690","key":"10.1016\/j.bioorg.2025.109028_bb0175","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature25460","article-title":"Mitochondrial translation requires folate-dependent tRNA methylation","volume":"554","author":"Morscher","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109028_bb0180","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.109028_bb0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109028_bb0190","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:28:59Z","timestamp":1762223339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":38,"alternative-id":["S0045206825009083"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109028","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of W478, a novel SHMT2 inhibitor for the treatment of esophageal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109028"}}